Demographics of infertility and management of unexplained infertility

Mohan S Kamath, Siladitya Bhattacharya

Research output: Contribution to journalArticle

21 Citations (Scopus)
4 Downloads (Pure)

Abstract

The cause of infertility is unexplained in about 22–28% of all infertile couples. The prognosis for spontaneous pregnancy in such couples is better than in those with diagnosed causes of infertility. Traditional treatment options in this group have included expectant management, clomifene citrate, intrauterine insemination with (super ovulation plus intrauterine insemination) or without (intrauterine insemination) super ovulation and in-vitro fertilisation. Despite being more expensive, empirical clomifene and intrauterine insemination in an unstimulated cycle do not improve the chances of live birth compared with expectant management. Although unlikely to be more effective than no treatment in couples with a reasonably good prognosis, super ovulation plus intrauterine insemination has been shown to be more effective than intrauterine insemination. Any potential advantage of super ovulation plus intrauterine insemination has to be balanced against the relatively high risk of iatrogenic multiple pregnancy. In-vitro fertilisation remains the treatment of choice in longstanding unresolved infertility and, when coupled with the use of elective single embryo transfer, can minimise the risk of multiple pregnancies. Data from randomised trials confirming the superiority of in-vitro fertilisation over expectant management is limited.
Original languageEnglish
Pages (from-to)729-738
Number of pages10
JournalBest Practice & Research Clinical Obstetrics & Gynaecology
Volume26
Issue number6
DOIs
Publication statusPublished - Dec 2012

Fingerprint

Insemination
Infertility
Demography
Ovulation
Fertilization in Vitro
Multiple Pregnancy
Clomiphene
Single Embryo Transfer
Live Birth
Citric Acid
Therapeutics
Pregnancy

Keywords

  • unexplained
  • expectant management
  • intra uterine insemination
  • super ovulation
  • clomifene citrate
  • in-vitro fertilisation

Cite this

Demographics of infertility and management of unexplained infertility. / Kamath, Mohan S; Bhattacharya, Siladitya.

In: Best Practice & Research Clinical Obstetrics & Gynaecology, Vol. 26, No. 6, 12.2012, p. 729-738.

Research output: Contribution to journalArticle

@article{8df3502151fc47eda477860498e17adf,
title = "Demographics of infertility and management of unexplained infertility",
abstract = "The cause of infertility is unexplained in about 22–28{\%} of all infertile couples. The prognosis for spontaneous pregnancy in such couples is better than in those with diagnosed causes of infertility. Traditional treatment options in this group have included expectant management, clomifene citrate, intrauterine insemination with (super ovulation plus intrauterine insemination) or without (intrauterine insemination) super ovulation and in-vitro fertilisation. Despite being more expensive, empirical clomifene and intrauterine insemination in an unstimulated cycle do not improve the chances of live birth compared with expectant management. Although unlikely to be more effective than no treatment in couples with a reasonably good prognosis, super ovulation plus intrauterine insemination has been shown to be more effective than intrauterine insemination. Any potential advantage of super ovulation plus intrauterine insemination has to be balanced against the relatively high risk of iatrogenic multiple pregnancy. In-vitro fertilisation remains the treatment of choice in longstanding unresolved infertility and, when coupled with the use of elective single embryo transfer, can minimise the risk of multiple pregnancies. Data from randomised trials confirming the superiority of in-vitro fertilisation over expectant management is limited.",
keywords = "unexplained, expectant management, intra uterine insemination, super ovulation, clomifene citrate, in-vitro fertilisation",
author = "Kamath, {Mohan S} and Siladitya Bhattacharya",
year = "2012",
month = "12",
doi = "10.1016/j.bpobgyn.2012.08.001",
language = "English",
volume = "26",
pages = "729--738",
journal = "Best Practice & Research Clinical Obstetrics & Gynaecology",
issn = "1521-6934",
publisher = "Bailliere Tindall Ltd",
number = "6",

}

TY - JOUR

T1 - Demographics of infertility and management of unexplained infertility

AU - Kamath, Mohan S

AU - Bhattacharya, Siladitya

PY - 2012/12

Y1 - 2012/12

N2 - The cause of infertility is unexplained in about 22–28% of all infertile couples. The prognosis for spontaneous pregnancy in such couples is better than in those with diagnosed causes of infertility. Traditional treatment options in this group have included expectant management, clomifene citrate, intrauterine insemination with (super ovulation plus intrauterine insemination) or without (intrauterine insemination) super ovulation and in-vitro fertilisation. Despite being more expensive, empirical clomifene and intrauterine insemination in an unstimulated cycle do not improve the chances of live birth compared with expectant management. Although unlikely to be more effective than no treatment in couples with a reasonably good prognosis, super ovulation plus intrauterine insemination has been shown to be more effective than intrauterine insemination. Any potential advantage of super ovulation plus intrauterine insemination has to be balanced against the relatively high risk of iatrogenic multiple pregnancy. In-vitro fertilisation remains the treatment of choice in longstanding unresolved infertility and, when coupled with the use of elective single embryo transfer, can minimise the risk of multiple pregnancies. Data from randomised trials confirming the superiority of in-vitro fertilisation over expectant management is limited.

AB - The cause of infertility is unexplained in about 22–28% of all infertile couples. The prognosis for spontaneous pregnancy in such couples is better than in those with diagnosed causes of infertility. Traditional treatment options in this group have included expectant management, clomifene citrate, intrauterine insemination with (super ovulation plus intrauterine insemination) or without (intrauterine insemination) super ovulation and in-vitro fertilisation. Despite being more expensive, empirical clomifene and intrauterine insemination in an unstimulated cycle do not improve the chances of live birth compared with expectant management. Although unlikely to be more effective than no treatment in couples with a reasonably good prognosis, super ovulation plus intrauterine insemination has been shown to be more effective than intrauterine insemination. Any potential advantage of super ovulation plus intrauterine insemination has to be balanced against the relatively high risk of iatrogenic multiple pregnancy. In-vitro fertilisation remains the treatment of choice in longstanding unresolved infertility and, when coupled with the use of elective single embryo transfer, can minimise the risk of multiple pregnancies. Data from randomised trials confirming the superiority of in-vitro fertilisation over expectant management is limited.

KW - unexplained

KW - expectant management

KW - intra uterine insemination

KW - super ovulation

KW - clomifene citrate

KW - in-vitro fertilisation

U2 - 10.1016/j.bpobgyn.2012.08.001

DO - 10.1016/j.bpobgyn.2012.08.001

M3 - Article

VL - 26

SP - 729

EP - 738

JO - Best Practice & Research Clinical Obstetrics & Gynaecology

JF - Best Practice & Research Clinical Obstetrics & Gynaecology

SN - 1521-6934

IS - 6

ER -